CME Information
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Carden Jennings Publishing. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
Physician Credit
Medical Education Resources designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
Medical Education Resources designates this live activity for a maximum of 28 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 28 contact hours.
Physician Assistant Credit
Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 28 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.
Wednesday, January 31st, 2024
| 6:00 a.m. – 6:50 a.m. | Breakfast with Exhibitors |
| 6:50 a.m. – 7:00 a.m. | Welcome Announcements |
| 7:00 a.m. – 7:20 a.m. | Focal Therapy for Prostate Cancer – Fernando J. Kim, MD, MBA, FACS |
| 7:20 a.m. – 7:40 a.m. | Role of neoadjuvant/adjuvant immunotherapy in patients with localized Renal Cell Carcinoma: the PROSPER trial and beyond – Mohammed E. Allaf, MD |
| 7:40 a.m. – 8:00 a.m. | Orthotopic bladder substitutes in females: why we should do it – Prof. Dr. med. Fiona C. Burkhard |
| 8:00 a.m. – 8:20 a.m. | Priapism: How do we manage and how do we learn how to manage in 2024 – Thomas J. Walsh, MD, MBA, MS |
| 8:20 a.m. – 8:40 a.m. | Lasers in Stone Surgery—principles and tips/tricks for lasers in URS, PCNL – Seth K. Bechis, MD |
| 8:40 a.m. – 9:00 a.m. | Break with Exhibitors |
| 9:00 a.m.– 9:20 a.m. | Testosterone treatment and prostate cancer risk – Thomas J. Walsh, MD, MBA, MS |
| 9:20 a.m. – 9:40 a.m. | Novel imaging for renal mass characterization – Mohammed E. Allaf, MD |
| 9:40 a.m. – 10:00 a.m. | Management of Neurogenic Lower Urinary Tract Dysfunction: Surgical Options with Reference to the Guidelines – Prof. Dr. med. Fiona C. Burkhard |
| 10:00 a.m. – 10:20 a.m. | PSA Screening Update – Gerald L. Andriole, Jr., MD |
| 10:20 a.m. – 10:40 a.m. | Game changers in prostate cancer diagnostics: Imaging probably wins the most – John W. Davis, MD, FACS |
| 10:40 a.m. – 11:00 a.m. | Emerging Topics in Ureteroscopy: Pressure, Temperature & Suction – Seth K. Bechis, MD |
| 11:00 a.m. – 11:20 a.m. | Break with Exhibitors |
| 11:20 a.m. – 11:40 a.m. | The artificial urinary sphincter in complex situations – Margit M. Fisch, MD, FEAPU, FEBU |
| 11:40 a.m. – 12:00 p.m. | Functional Urology: A new subspecialty or rebranding – Brian J. Flynn, MD |
| 12:00 p.m. – 2:30 p.m. | Break |
| 2:30 p.m. – 3:00 p.m. | Hors d’oeuvres with Exhibitors |
| 3:00 p.m. – 7:40 p.m. | Critique Panel Discussion |
Thursday, February 1st, 2024
| 6:00 a.m. – 6:50 a.m. | Industry Sponsored Breakfast |
| 7:00 a.m. – 7:20 a.m. | Life Expectancy as it Relates to the Treatment of Urologic Cancers – Thomas W. Jarrett, MD |
| 7:20 a.m. – 7:40 a.m. | The making of the ileal orthotopic bladder substitute with an afferent tubular segment: in memory of Prof. Urs Studer – Prof. Dr. med. Fiona C. Burkhard |
| 7:40 a.m. – 8:00 a.m. | Micro ultrasound and MRI of the prostate – Gerald L. Andriole, Jr., MD |
| 8:00 a.m. – 8:20 a.m. | The association between testosterone treatment and incident of cardiovascular events among testosterone deficient U.S. Veterans – Thomas J. Walsh, MD, MBA, MS |
| 8:20 a.m. – 8:40 a.m. | The battle of biopsies: results of a multi institutional randomized trail of trans reactant vs transperitoneal prostate biopsy – Mohammed E. Allaf, MD |
| 8:40 a.m. – 9:00 a.m. | Break with Exhibitors |
| 9:00 a.m. – 9:20 a.m. | Should MIST be first line treatment for BPH? – Seth K. Bechis, MD |
| 9:20 a.m. – 9:40 a.m. | Testosterone therapy in the prostate cancer patient – John P. Mulhall, MD |
| 9:40 a.m. – 10:00 a.m. | Surgical planning for robotic prostatectomy when you are not the first surgeon to the site: access and salvage challenges – John W. Davis, MD, FACS |
| 10:00 a.m. – 3:30 p.m. | Break |
| 3:30 p.m. – 4:00 p.m. | Hors d’oeuvres with Exhibitors |
| 4:00 p.m. – 4:20 p.m. | Immortal field of longevity in mens health – Jesse N. Mills, MD |
| 4:20 p.m. – 7:40 p.m. | Critique Panel Discussion |
Friday, February 2nd, 2024
| 6:30 a.m. – 6:50 a.m. | Breakfast with Exhibitors |
| 7:00 a.m. – 7:20 a.m. | Simplified management of male genital pain – Ryan Terlecki, MD |
| 7:20 a.m. – 7:40 a.m. | Management of late complications after continent urinary diversion: case presentations – Prof. Dr. med. Fiona C. Burkhard |
| 7:40 a.m. – 8:00 a.m. | Management of Small Renal Tumors: A Guidelines Based Approach – Mohammed E. Allaf, MD |
| 8:00 a.m. – 8:20 a.m. | Stone Volume is a Better Predictor of Spontaneous Stone Passage – Seth K. Bechis, MD |
| 8:20 a.m. – 8:40 a.m. | Cannabis use and male reproductive health: Who knew? – Thomas J. Walsh, MD, MBA, MS |
| 8:40 a.m. – 9:00 a.m. | Break with Exhibitors |
| 9:00 a.m. – 9:20 a.m. | Making Sense of BPH: Which Treatment for Which Patient – Review of Guidelines for BP – Seth K. Bechis, MD |
| 9:20 a.m. – 9:40 a.m. | Update on Penile Implants: Best Practice and taking care of complications – Jesse N. Mills, MD |
| 9:40 a.m. – 10:00 a.m. |
Robotic partial nephrectomy for complex cases: planning the surgical strategy – Pierluigi Bove, MD |
| 10:00 a.m. – 3:30 p.m. | Break |
| 3:30 p.m. – 4:00 p.m. | Hors d’oeuvres with Exhibitors |
| 4:00 p.m. – 4:20 p.m. | Insights into PDE5 inhibitors: 25 years experience – John P. Mulhall, MD |
| 4:20 p.m. – 4:40 p.m. | Female Stress urinary Incontinence 2023 – Brian J. Flynn, MD |
| 4:40 p.m. – 7:40 p.m. | Critique Panel Discussion |
Saturday, February 3rd, 2024
| 6:00 a.m. – 7:00 a.m. | Breakfast with Exhibitors |
| 7:00 a.m. – 7:20 a.m. | Role of lymphadenectomy in the surgical treatment of clinical localized prostate cancer – Mohammed E. Allaf, MD |
| 7:20 a.m. – 7:40 a.m. | Understanding bladder outlet obstruction: pathophysiology and diagnosis – Prof. Dr. med. Fiona C. Burkhard |
| 7:40 a.m. – 8:00 a.m. | Trends of Urinary diversion: declining popularity of continent diversion – Margit M. Fisch, MD, FEAPU, FEBU |
| 8:00 a.m. – 8:20 a.m. | Early Continence Recovery after Robotic Assisted Radical Prostatectomy: The Role of Prostatic Shape – Pierluigi Bove, MD |
| 8:20 a.m. – 8:40 a.m. | Erectile dysfunction treatment: state of the art care in 2024 – Thomas J. Walsh, MD, MBA, MS |
| 8:40 a.m. – 9:00 a.m. | Break with Exhibitors |
| 9:00 a.m. – 9:20 a.m. | Renal Ablation Technologies: Impact on the Treatment of Small Renal Masses – Thomas W. Jarrett, MD |
| 9:20 a.m. – 9:40 a.m. | Setting expectations in prosthetic urology – Ryan Terlecki, MD |
| 9:40 a.m. – 10:00 a.m. | Gender disparity in residency case volumes? – Ouida Westney, MD |
| 10:00 a.m. – 10:20 a.m. | Robotic approaches to treat BPH and stones – Giorgio Bozzini, MD |
| 10:20 a.m. – 10:40 a.m. | TBD |
| 10:40 a.m. – 4:00 p.m. | Break |
| 4:00 p.m. – 7:30 p.m. | Critique Panel Discussion |
| 7:30 p.m. | Awards Banquet |